-+ 0.00%
-+ 0.00%
-+ 0.00%

AMGEN: GRADE 3 OR HIGHER ADVERSE EVENTS OCCURRED IN 20.9% WITH IMDELLTRA PLUS IMFINZI VS 10.8% WITH IMFINZI ALONE

Reuters·10/24/2026 14:32:06